Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
14:30:00 13/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 6,926.00 JPY | +1.48% |
|
+0.55% | +43.25% |
| Market Cap | 11,064B 69.2B 62.71B 58B 52.33B 98.62B 6,525B 102B 697B 276B 3,485B 260B 254B | P/E 2027 * |
49.2x | P/E 2028 * | 33.9x |
|---|---|---|---|---|---|
| Enterprise Value | 15,013B 93.91B 85.1B 78.71B 71.02B 134B 8,854B 139B 946B 375B 4,730B 352B 345B | EV / Sales 2027 * |
3.18x | EV / Sales 2028 * | 3.06x |
| Free-Float |
99.18% | Yield 2027 * |
2.95% | Yield 2028 * | 3.01% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
Tradegate
| TKD | Real-time | |
|
Boerse Muenchen
| TKD | Real-time | |
|
Börse Stuttgart
| TKD | Delayed | |
|
OTC Markets
| TKPHF | Delayed | |
|
Sapporo S.E.
| 4502 | Delayed | |
|
Deutsche Boerse AG
| TKD | Delayed | |
|
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +1.48% | ||
| 1 week | +0.55% | ||
| Current month | +4.13% | ||
| 1 month | +18.53% | ||
| 3 months | +24.52% | ||
| 6 months | +34.02% | ||
| Current year | +43.25% |
| 1 week | 6,517 |  | 6,926 |
| 1 month | 5,824 | | 6,989 |
| Current year | 4,710 | | 6,989 |
| 1 year | 4,346 | | 6,989 |
| 3 years | 3,852 | | 6,989 |
| 5 years | 2,993 | | 6,989 |
| 10 years | 2,894.5 | | 6,989 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 61 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/11/26 | Sell | Executive/Senior Manager | -55,617 | 0.0035% | ||
| 2/11/26 | Sell | Executive/Senior Manager | -46,609 | 0.0029% | ||
| 14/9/26 | Sell | Executive/Senior Manager | -34,535 | 0.0022% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.48% | +0.55% | +60.58% | +66.77% | 68.15B | |
| +1.26% | +5.77% | +41.83% | +141.51% | 1,271B | |
| +0.79% | +4.93% | +47.00% | +94.06% | 683B | |
| +0.20% | +2.36% | +26.50% | +112.88% | 520B | |
| -0.44% | +3.32% | +39.36% | +70.94% | 389B | |
| +0.55% | +0.56% | +61.57% | +45.73% | 362B | |
| -0.12% | -0.04% | +28.04% | +59.86% | 304B | |
| +0.37% | -0.43% | +3.43% | +38.57% | 286B | |
| -0.30% | +1.17% | +38.48% | +74.21% | 253B | |
| +0.08% | +0.30% | +36.21% | +121.39% | 208B | |
| Average | +0.30% | +1.47% | +38.30% | +82.59% | 434B | |
| Weighted average by Cap. | +0.46% | +2.62% | +38.57% | +97.78% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,715B 29.49B 26.73B 24.72B 22.3B 42.03B 2,781B 43.51B 297B 118B 1,485B 111B 108B | 4,827B 30.19B 27.36B 25.31B 22.83B 43.03B 2,847B 44.55B 304B 121B 1,521B 113B 111B |
| Net income | 216B 1.35B 1.22B 1.13B 1.02B 1.92B 127B 1.99B 13.57B 5.38B 67.9B 5.06B 4.95B | 343B 2.14B 1.94B 1.8B 1.62B 3.06B 202B 3.16B 21.59B 8.56B 108B 8.05B 7.88B |
| Net Debt | 3,950B 24.7B 22.39B 20.71B 18.68B 35.21B 2,329B 36.45B 249B 98.63B 1,244B 92.7B 90.74B | 3,714B 23.23B 21.05B 19.47B 17.57B 33.11B 2,191B 34.28B 234B 92.76B 1,170B 87.19B 85.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | JP¥6,926.00 | +1.48% | 4,419,400 |
| 12/11/26 | JP¥6,825.00 | +2.28% | 3,600,600 |
| 11/11/26 | JP¥6,673.00 | +1.21% | 4,376,500 |
| 10/11/26 | JP¥6,593.00 | -1.20% | 3,457,000 |
| 09/11/26 | JP¥6,673.00 | +1.72% | 4,942,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
